Repositorio Digital de la UPF
Publication
Artículo científico (JournalArticle)
Guidelines for releasing a variant effect predictor
Computational methods for assessing the likely impacts of mutations, known as variant effect predictors (VEPs), are widely used in the assessment and interpretation of human genetic variation, as well as in other applications like protein engineering. Many different VEPs have been released, and there is tremendous variability in their underlying algorithms, outputs, and the ways in which the methodologies and predictions are shared. This leads to considerable difficulties for users trying to navigate the selection and application of VEPs. Here, to address these issues, we provide guidelines and recommendations for the release of novel VEPs., MD and J Frazer are supported by the Spanish Ministry of Science and Innovation (PID2022-140793NA-I00). KLL received funding from the Novo Nordisk Foundation (NNF18OC0033950). DMM received funding from the National Institutes of Health (NIH) (R35GM133613). RO and DSM are supported by the Chan Zuckerberg Initiative Neurodegeneration Challenge Network (CZI2018-191853). LM, LMS, and FPR received funding from the NIH (RM1HG010461), and FPR also received funding from NIH grant UM1HG011989. J Foreman received funding from the Wellcome Trust (WT223718/Z/21/Z). AMG received funding from the NIH (R35GM150465). BL received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 883742). DSM received funding from the NIH (1R01CA260415). AFR received funding from the NIH (UM1HG011969, RM1HG010461, R01HG013025) and grant funding from the Australian Government. JAM is supported by the ERC (grant agreement No. 101001169) and by the Medical Research Council (MRC) Human Genetics Unit core grant (MC_UU_00035/9).